SCHEMBL6948674

SCHEMBL6948674

CC(C)CC[C@](CBr)(O[C@@](CBr)(CCC(C)C)c1ccccc1)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
RIPK1 Q13546 1/20 0.33
TTR P02766 1/20 0.33
MAPT P10636 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.31
OPRM1 P35372 2/20 0.31
OPRD1 P41143 2/20 0.31
OPRK1 P41145 2/20 0.31
HTT P42858 1/20 0.30
ATM Q13315 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
KIF11 P52732 4/20 0.30
AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21462898 0.73 RIPK1 (0.40) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL872854 0.71 CYP2C19 (0.46) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL6681496 0.70 TAAR1 (0.50) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL4137948 0.69 GRIN1 (0.36) CYP2D6ALDH1A1CYP2C19HSD17B10MAPK1
SCHEMBL12356880 0.68 ALDH1A1 (0.41) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL907893 0.68 CYP2D6 (0.39) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
Ammonia Solution, Strong SCHEMBL6230799 0.67 ALDH1A1 (0.39) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL17965831 0.67 CYP2D6 (0.35) CYP2D6ALDH1A1CYP2C19HSD17B10MEN1
SCHEMBL27278714 0.66 KCNN4 (0.43) ALDH1A1CYP2C19MAPK1KIF11
SCHEMBL3997340 0.64 ALDH1A1 (0.49) CYP2D6ALDH1A1CYP2C19HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003103653-A1 METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed